Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $930 at Jefferies

October 1, 2026 12:43 PM
Jefferies analyst Akash Tewari raised the price target on Regeneron Pharma (NASDAQ: REGN) to $930.00 (from $870.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change